Effects of liraglutide on gallbladder emptying: A randomized, placebo‐controlled trial in adults with overweight or obesity

AIMS: Treatment with liraglutide 3.0 mg has been associated with gallbladder‐related adverse events. To conduct a single‐centre, double‐blind, 12‐week trial comparing the effect of 0.6 mg liraglutide and steady‐state liraglutide 3.0 mg with placebo on gallbladder emptying in adults with body mass in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nexøe‐Larsen, Christina C., Sørensen, Pernille H., Hausner, Helene, Agersnap, Mikkel, Baekdal, Mille, Brønden, Andreas, Gustafsson, Lea N., Sonne, David P., Vedtofte, Louise, Vilsbøll, Tina, Knop, Filip K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220792/
https://www.ncbi.nlm.nih.gov/pubmed/29892986
http://dx.doi.org/10.1111/dom.13420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220792/
https://www.ncbi.nlm.nih.gov/pubmed/29892986
http://dx.doi.org/10.1111/dom.13420

Ejemplares similares